In 2017, India set itself a health-spending target for 2025. As that deadline arrived, actual spending stood at less than four-fifths of the goal.
General Science · GenSci0035
43.4%
Out-of-pocket share of India’s health spending, 2022-23
Down from 62.6% in 2014-15
₹5 lakh
PM-JAY cover per family, per year
12.7 cr
Hospital admissions authorised, mid-2026
₹1.52 lakh cr
Saved in out-of-pocket costs (PM-JAY)
16%
NPPA’s trade-margin cap on scheduled drugs
Govt health spending vs. NHP 2017’s own 2025 target1.9% / 2.5% of GDP
A target India set for itself, and missed
The National Health Policy asked for 2.5% of GDP on health by 2025. As that deadline arrived, actual spending stood at 1.9% — real progress, but well short of the goal.
Must Know
- Out-of-pocket expenditure (OOPE) is money patients pay directly, not through insurance or the government. It’s the main measure of how “affordable” healthcare actually is.
- India’s OOPE share of total health spending has fallen a lot. It dropped from 62.6% in 2014-15 to 43.4% in 2022-23, per National Health Accounts Estimates.
- The main scheme behind this shift is Ayushman Bharat PM-JAY. It offers ₹5 lakh of health insurance cover per family, per year.
- As of mid-2026, PM-JAY has authorised about 12.7 crore hospital admissions. It has saved families over ₹1.52 lakh crore in out-of-pocket costs, per the Economic Survey 2024-25.
- India’s own National Health Policy, 2017 set a target: government health spending at 2.5% of GDP by 2025. As that deadline arrived, actual spending stood at just 1.9%.
Good to Know
- On the drug-pricing side, the NPPA (National Pharmaceutical Pricing Authority) caps trade margins on essential medicines.
- Under the Drug Price Control Order, price-controlled formulations carry a combined retail-distributor trade margin cap of 16%.
- Hospital quality itself is assessed by NABH (National Accreditation Board for Hospitals), under the umbrella Quality Council of India (QCI).
- Parliament’s own Standing Committee heard evidence from all of these bodies. NPPA, QCI, NABH, and the Drugs Controller General of India (DCGI) all testified in a July 2026 session on this exact subject.
- Over 42 crore Ayushman cards had been issued to beneficiaries, as of October 2025.
Test Yourself
Great to Know
- Generic medicines are a direct lever on affordability. See IndEco0129 — Jan Aushadhi Scheme: Affordable Generic Medicines in India.
- Who’s actually closing the health-spending gap is a genuine split. Since 2017, state governments have raised their own health spending from 0.67% to 1.1% of GDP. The Union Government’s own share has actually fallen, from a pandemic-era 0.37% to 0.29% in 2025-26.
- The India’s Public Sector Health Care System article covers the structural side of this picture — why public health care leans curative over preventive, and how the Centre-State division of responsibility works.
Current Affairs
- 6 August 2026: The Rajya Sabha’s Department-Related Parliamentary Standing Committee on Health and Family Welfare considered and adopted its 176th Report. The Committee is chaired by Ram Gopal Yadav. The report’s title: “Affordability and Accessibility of Healthcare Facilities in Public and Private Sector.” The Committee made a total of 368 recommendations in the report. (Source: PRS India) (Source: PIB)
- 17 July 2026: As part of examining this subject, the Committee heard oral evidence from the Secretary of NPPA, the chairpersons of QCI and NABH, and officials from DCGI and CDSCO. (Source: PRS India)
Leave a Reply